Suchergebnisse - "Drake, Charles G"

PubPharm (479)

51

Differential Immune Modulation With Carbon-Ion Versus Photon Therapy

enthalten in: International journal of radiation oncology, biology, physics | 2021

von Spina, C. | Tsuruoka, C. | Mao, W. | +8

52

Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time : An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer

enthalten in: European urology oncology | 2021

von Kates, M. | Nirschl, T. | Baras, A. | +9

53

PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice

enthalten in: Gastroenterology | 2021

von Kim, W. | Chu, T. | Nienhüser, H. | +9

CommentIn: Gastroenterology. 2021 Aug;161(2):727. - PMID 33798523

54

Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model : Multidimensional Analyses

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Aggen, D. | Ager, C. | Obradovic, A. | +13

55

Reply to Ethan B. Ludmir, Zachary R. McCaw, and Lee-Jen Wei's Letter to the Editor re : Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032. Interpreting the Effect of Ipilimumab following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer

enthalten in: European urology | 2021

von McHenry, M. | Drake, C. | Fizazi, K.

CommentOn: Eur Urol. 2020 Dec;78(6):822-830. - PMID 32811715

56

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer : A phase‐2 nonrandomized clinical trial

enthalten in: The Prostate | 2021

von Shenderov, E. | Boudadi, K. | Fu, W. | +14

57

Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)

enthalten in: The Prostate | 2020

von Harshman, L. | Wang, V. | Hamid, A. | +6

58

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

enthalten in: European urology | 2020

von Fizazi, K. | Drake, C. | Beer, T. | +23

CommentIn: Eur Urol. 2020 Dec;78(6):831-833. - PMID 32933793

59

Cytoreductive nephrectomy for metastatic renal cell carcinoma, the ultimate urologic 'Choosing Wisely' campaign : a narrative review

enthalten in: Translational cancer research | 2020

von Tabakin, A. | Stein, M. | Anderson, C. | +2

60

A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer

enthalten in: Cancer research | 2020

von Gonda, T. | Fang, J. | Salas, M. | +11

CommentIn: Cancer Res. 2020 Nov 1;80(21):4610-4611. - PMID 33144295